Related Experiment Video
Updated: Jul 10, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.6K
Future of left atrial appendage interventions
Matteo Casenghi1, Sara Corradetti2, Emiliano Navarra2
1Sant'Andrea Hospital, Rome, Italy - matcasenghi@hotmail.it.
Minerva Cardiology and Angiology
|June 6, 2024
Summary
Percutaneous left atrial appendage occlusion (LAAO) is a low-risk procedure for preventing stroke in atrial fibrillation patients. Further research is needed to optimize safety, efficacy, and standardization for wider adoption.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Percutaneous left atrial appendage occlusion (LAAO) is an emerging procedure for stroke prevention in patients with atrial fibrillation.
- While recognized as relatively low-risk, LAAO requires further optimization to compete with newer oral anticoagulants.
- Challenges include comprehensive data acquisition, standardized planning, and procedural simplification.
Purpose of the Study:
- To provide an overview of future opportunities for enhancing LAAO safety and efficacy.
- To establish LAAO as a mainstream strategy for stroke and systemic embolism prevention.
- To address patients with atrial fibrillation and contraindications to anticoagulant drugs.
Main Methods:
- Review of current clinical practices and challenges in LAAO.
- Analysis of existing data on safety and efficacy.
- Discussion of potential strategies for procedural optimization and standardization.
Main Results:
- LAAO is a viable, low-risk alternative for stroke prevention in specific patient populations.
- Opportunities exist to improve data collection, pre-procedural planning, and procedural techniques.
- Standardization and further evidence generation are key to establishing LAAO as a mainstream therapy.
Conclusions:
- Enhancing procedural safety and efficacy through data acquisition and standardization is crucial for LAAO.
- LAAO holds significant potential as a primary stroke prevention strategy for patients with atrial fibrillation and contraindications to anticoagulation.
- Continued research and development are necessary to fully realize the benefits of LAAO.
Related Concept Videos
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...